Premium
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems
Author(s) -
CAMMÀ C.,
MARCO V. DI,
CABIBBO G.,
LATTERI F.,
SANDONATO L.,
PARISI P.,
ENEA M.,
ATTANASIO M.,
GALIA M.,
ALESSI N.,
LICATA A.,
LATTERI M. A.,
CRAXÌ A.
Publication year - 2008
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2008.03692.x
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , gastroenterology , cohort , portal vein thrombosis , liver cancer , proportional hazards model , bilirubin , carcinoma , surgery
Summary Background A major problem in assessing the likelihood of survival of patients with hepatocellular carcinoma (HCC) arises from a lack of models capable of predicting outcome accurately. Aim To compare the ability of the Italian score (CLIP), the French classification (GRETCH) and the Barcelona (BCLC) staging system in predicting survival in patients with HCC. Methods We included 406 consecutive patients with cirrhosis and HCC. Seventy‐eight per cent of patients had hepatitis C. Independent predictors of survival were identified using the Cox model. Results One‐hundred and seventy‐eight patients were treated, while 228 were untreated. The observed mortality was 60.1% in treated patients and 84.9% in untreated patients. Among treated patients, albumin, bilirubin and performance status were the only independent variables significantly associated with survival. Mortality was independently predicted by bilirubin, alpha‐fetoprotein and portal vein thrombosis in untreated patients. CLIP achieved the best discriminative capacity in the entire HCC cohort and in the advanced untreatable cases, while BCLC was the ablest in predicting survival in treated patients. Conclusions Overall predictive ability of BCLC, CLIP and GRETCH staging systems was not satisfactory, and was not uniform for treated patients and untreated patients. None of the scoring systems provided confident prediction of survival in individual patients.